Viewing Study NCT05832892


Ignite Creation Date: 2025-12-24 @ 3:16 PM
Ignite Modification Date: 2026-01-04 @ 1:03 PM
Study NCT ID: NCT05832892
Status: UNKNOWN
Last Update Posted: 2024-06-14
First Post: 2023-04-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Surufatinib Combined With KN046 and AG Regimen Chemotherapy as First-Line Treatment for Unresectable Advanced Pancreatic Cancer
Sponsor: Shanghai Zhongshan Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module